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INTRODUCTION
Several reviews on the topic of gender differences in 
pain mechanisms, control and treatments have been 
published in the last two decades [1]. The increasing 
literature refers to a broad range of topics, including 
preclinical studies on mechanisms underlying male and 
female differences in nociception and its control, clini-
cal research on gender differences in pain perception 
and modulation, epidemiological investigations of sex 
differences in pain prevalence and a growing number of 
studies examining sex differences in responses to pain 
therapies [1].
In this brief review, we summarize important findings 
regarding gender and pain and we will discuss findings 
regarding sex differences in animal models of pain and 
in clinical pain prevalence and severity. Moreover, we 
will review recent research exploring sex differences in 
responses to pain treatment, followed by a brief discus-
sion of hormonal mechanisms underlying the sex dif-
ferences in responses to pain and its treatment. We will 
conclude with a brief commentary on future directions 
in this interesting field of knowledge.
SEX PREVALENCE AND EPIDEMIOLOGY IN 
CLINICAL PAIN
Since the pioneering work of Berkley [2], large-scale 
epidemiological studies have consistently revealed a 
higher female prevalence of several painful diseases. 
Women report more severe levels of pain, more fre-
quent pain in more areas of the body and pain of longer 
duration than men. Such painful conditions particularly 
involve the head and neck, e.g. migraine, chronic ten-
sion-type headache and temporomandibular disorders, 
but also include fibromyalgia, irritable bowel syndrome 
and interstitial cystitis [3]. However, while women are 
more affected by these chronic painful syndromes, the 
condition is not exclusive to this sex, and there are also 
conditions more common in men than in women such 
as cluster headache, a typical male pathology. More-
over, despite these findings the relationship between 
gender and pain is not simple since other studies have 
found no sex differences or inconsistent results when 
examining pain severity in clinical populations [3]. 
Some of the observed differences can arise from spe-
cific recurrent problems occurring over a long period 
of a woman’s life such as gynaecological syndromes, as 
well as from the greater female longevity, or are related 
to diseases with a higher male than female prevalence. 
Furthermore, the prevalence of different kinds of pain 
in both sexes can change across the lifespan, as occurs 
for migraine, fibromyalgia, temporomandibular disor-
ders, gastrointestinal, abdominal, joint and back pain. 
As recently reported, menopause can play an important 
role in changing pain sensitivity. Interestingly, although 
the loss of estrogen can lead to a decrease in life-long 
painful conditions such as headache, menopause can 
also be accompanied by “new” painful conditions such 
as osteoporosis and joint inflammation [4]. No sex dif-
ferences have been reported for some pathological con-
ditions such as cancer [5], although sex differences in 
the type of cancer and its stage and in the effectiveness 
of pain treatments in these clinical conditions could 







There is much evidence to suggest that gender is an important factor in the modulation 
of pain. Literature data strongly suggest that men and women differ in their responses 
to pain: they are more variable in women than men, with increased pain sensitivity and 
many more painful diseases commonly reported among women. Gender differences in 
pharmacological therapy and non-pharmacological pain interventions have also been re-
ported, but these effects appear to depend on the treatment type and characteristics. 
It is becoming very evident that gender differences in pain and its relief arise from an 
interaction of genetic, anatomical, physiological, neuronal, hormonal, psychological and 
social factors which modulate pain differently in the sexes. Experimental data indicate 
that both a different modulation of the endogenous opioid system and sex hormones are 
factors influencing pain sensitivity in males and females. This brief review will examine 
the literature on sex differences in experimental and clinical pain, focusing on several 
biological mechanisms implicated in the observed gender-related differences.


















also influence the presence, magnitude and direction 
of sex differences in cancer pain [3]. Other confound-
ing factors that can influence sex difference estimates in 
pain are the reported gender differences in pain symp-
toms and signs of some syndromes such as appendicitis, 
migraine, IBS, rheumatoid arthritis and coronary artery 
diseases [6]. It is recognized that psychological and 
socio-cultural mechanisms can influence pain percep-
tion, expression and tolerance in both sexes, thus con-
founding gender-related pain analysis. Nevertheless, 
the overall findings from epidemiological and clinical 
studies demonstrate that women are at higher risk for 
many common pain conditions than men. Data on pain 
intensity are less consistent and influenced by several 
methodological factors, including mode of patient se-
lection in clinical studies and the sex differences in the 
effects of pain treatments.
SEX AND EXPERIMENTALLY INDUCED PAIN
Differences in responses to experimental pain in both 
sexes have been investigated mainly in healthy people 
using a wide variety of stimuli (mechanical, electrical, 
thermal, ischemic, chemical). Pain responses have been 
evaluated by different measures including time and 
intensity to the first sensation of pain, pain tolerance, 
and self-report measures of pain intensity. The results 
varied between studies regardless of the type of stimu-
lus used, indicating that sex differences in nociception 
depend on multiple factors such as the type of stimulus, 
testing or end point paradigm, body location, temporal 
rhythms, reproductive status and age, the presence of 
disease or illness [6]. In contrast, a recent systematic 
review concluded that the last ten years of experimen-
tal research did not provide clear and consistent results 
concerning sex differences in human pain sensitivity 
[7]. However, from the data used for this review and 
the analysis of the studies, it appears that females feel 
pain with greater sensitivity than males, although the 
statistical significance of the sex difference varies across 
measures, as previously reported [6]. On the other 
hand, it is interesting to note that despite similar behav-
ioural responses by men and women to a painful stimu-
lus (pain intensity, threshold), some neurophysiological 
measurements (fNMR, PET) often show a different or 
opposite response to the same stimulus [8]. These data 
strongly indicate a different functional involvement 
of the central nervous system with possibly ‘different’ 
plastic changes in those areas probably involved in pain 
chronicization.
SEX DIFFERENCES AND PAIN TREATMENT
The response to pain therapy (drugs, somatic ma-
nipulations, situational adjustment) appears to be sex-
related. Several studies based on analgesic and adju-
vant drug consumption have documented that women 
consume and are prescribed more drugs than men, and 
only a part of this treatment is used to alleviate gynae-
cological pain [6]. However, lower opioid consumption 
has also been reported in post-operative women [9], 
although this result may depend on the type of surgi-
cal procedure or arise from increased analgesic side ef-
fects in women [10]. A lack of sex-specific effects for 
μ-mediated opioid analgesia was recently reported, but 
when the analyses were restricted to patient-controlled 
analgesia (PCA) or when only PCA morphine studies 
were considered, robust analgesic effects for women 
appeared [11]. Similar results were obtained in studies 
in which analgesic responses were experimentally as-
sessed, suggesting greater morphine analgesia for wom-
en. No sex-dependent analgesic effects of mixed opi-
oids such as butorphanol, nalbuphine and pentazocine 
were found in experimental studies, although in clinical 
studies it was concluded that women exhibit greater an-
algesia than men in response to these analgesics [3].
As reported for clinical and experimental studies, sex 
differences have also been found in investigations of 
pain treatment. Women received sedatives more often 
for pain after surgery whereas men were more likely to 
receive analgesics [12], suggesting that women are at 
risk for under-treatment of pain. Several studies suggest 
that the differences in pain treatment between women 
and men are influenced by both patient and provider 
characteristics, an effect which may lead to disparities 
in pain management [13].
In regard to sex differences in non-pharmacological 
pain interventions, when patients were asked to focus 
on the sensory components of pain, men reported less 
pain than woman, whereas when they focused on af-
fective components of pain, women reported more 
pain than men [14]. In a study examining the effect of 
acceptance-based coping instructions on cold-pressor 
pain, women reported a lower pain threshold and tol-
erance level than men and the acceptance instructions 
only benefited women [15]. Recently a study investi-
gated whether men and women exhibited different 
outcomes after an intensive multimodal pain treatment 
program consisting of individual treatment as well as 
group therapy [16]. Pre-treatment parameters for pain, 
disability due to pain, pain duration and pain chronicity 
stage, as well as age or psychiatric comorbidities, did 
not differ between genders. The study demonstrated a 
considerable difference in the benefit for women com-
pared with men, and women consistently improved 
more in pain-related disabilities in daily life than men. 
These distinctions did not appear to be due to differ-
ences in pain duration, medication, psychiatric comor-
bidities, pain chronicity stage or application for a dis-
ability pension. Therefore, gender differences do not 
only refer to chronic pain prevalence, pain perception 
or experimental pain measurement, but also seem to 
have a clinically relevant impact on the response to pain 
therapy, even though the results of this kind of study are 
somewhat variable.
MECHANISMS OF SEX DIFFERENCES 
IN PAIN
As summarized above, gender differences contribute 
to individual differences in pain and its relief. However, 
the specific mechanisms underlying the observed dis-
parity are not yet clear and it has been suggested that an 
interaction of biological, psychological and socio-cul-
tural factors probably contributes to these differences.
Androgens and estrogens are essential for the devel-
opment and maintenance of the reproductive system 


















and many studies suggest that they also play an impor-
tant role in the observed differences between males and 
females in the response to pain and pain treatments. 
Changes in estrogen plasma levels were found to be 
correlated with recurrent pain in women [17] and post-
menopausal women undergoing estrogen replacement 
therapy showed an increased incidence of temporoman-
dibular (TM) joint pain [18]. However, TM joint pain 
and fibromyalgia are also related to the menstrual cycle 
phases, and rapid estrogen changes may also be associ-
ated with increased pain [19]. Fibromyalgia symptoms 
are associated with the luteal phase, when both estro-
gen and progesterone levels are high [20].
Pain perception varies according to the menstrual 
cycle phases in women with chronic pain perception, 
with patients rating pain significantly higher in some 
phases of the menstrual cycle than in others [21]. In 
experimental models of pain, estrogens appear to be 
pronociceptive since male rats injected intracerebro-
ventricularly with estradiol for two days showed higher 
levels of formalin-induced licking than rats injected 
with saline [22]. However, estrogens also seem to play 
an important role in inducing anti-nociception. Simu-
lation of pregnancy in ovariectomized rats, with high 
plasma levels of estrogens and progesterone, increased 
the pain threshold [23] and this effect was also present 
in males [24]. Recently the antinociceptive effect of es-
trogen was confirmed in a model of neuropathic pain 
in mice [25]. The authors demonstrated that male and 
female mice react differently to structural and func-
tional changes induced by sciatic nerve ligature, used 
as a model of neuropathic pain. Male mice showed a 
gradual decrease of allodynia and a complete recov-
ery while in females the allodynia and gliosis were still 
present four months after neuropathy induction. Ad-
ministration of 17β-estradiol was able to significantly 
attenuate this difference, reducing the allodynia and 
inducing a complete recovery also in female mice. Fur-
thermore, 17β-estradiol-treated mice showed a func-
tional improvement of the injured limb, a faster regen-
erative process of the peripheral nerves and decreased 
neuropathy-induced gliosis [25]. With regard to the ef-
fect of androgens on pain, an inverse relationship was 
found between plasma testosterone and work-related 
neck and shoulder disorders in female workers [26]. 
Other evidence for an analgesic effect of androgens is 
the clinical finding that the levels of gonadal and ad-
renal androgens such as testosterone and DHT are 
lower in both female and male rheumatoid arthritis pa-
tients than in controls. Interestingly, androgen admin-
istration induces a significant improvement of clinical 
symptoms, probably through inhibition of the immune 
system [27, 28]. In male rats, when supraphysiologi-
cal levels of testosterone were administered to both 
male and female rats, the licking duration, which was 
longer in female than male controls, decreased only in 
females whereas no decrease in flexing or jerking be-
haviour was observed [29]. These results indicate that a 
high level of testosterone did not affect the nociceptive 
input, since jerking and flexing were unchanged, but 
did induce a ‘male-like’ response in females with re-
gard to licking, the most complex supraspinal formalin-
induced response. This suggests that the already lower 
licking levels in males are kept low by testosterone and 
that females are sensitive to changes in testosterone 
plasma levels. Interestingly, these experimental data 
were recently confirmed in women [30].
The combined oral contraceptive pill (COCP) has 
been implicated in the development of a number of 
chronic pain conditions. Modern COCP formulations 
produce a low endogenous estradiol, low progesterone 
environment similar to the early follicular phase of the 
natural menstrual cycle, with a variable effect on serum 
androgen levels. Vincent and co-authors used behav-
ioural measures and functional magnetic resonance 
imaging to investigate the response to experimental 
thermal stimuli in healthy women, in both a natural and 
COCP-induced low endogenous estradiol state, to in-
vestigate whether alterations in central pain processing 
underlie these observations in COCP users. Although 
COCP users generally did not require lower tempera-
tures to obtain a fixed pain intensity, alterations in the 
brain response to these stimuli were observed. How-
ever, lower temperatures were required in a subgroup 
of COCP users with significantly reduced serum tes-
tosterone. Region-of-interest analysis revealed that, in 
key regions of the descending pain inhibitory system, 
activity in response to noxious stimulation varied with 
serum testosterone levels in both groups of women. 
Of particular interest, in COCP users, activity in the 
rostral ventromedial medulla increased with increasing 
testosterone whereas it was significantly reduced com-
pared to controls in those women with low testosterone. 
These findings suggest that, in a low endogenous estra-
diol state, testosterone may be a key factor in modu-
lating pain sensitivity via descending pathways. Specifi-
cally, failure to engage descending inhibition at the level 
of the rostral ventromedial medulla may be responsible 
for the reduction in temperature required by COCP us-
ers with low circulating testosterone.
Other experiments aimed at evaluating the long-term 
effect of a painful stimulus in rats confirmed that male 
gonadal hormones have an inhibitory, adaptive effect 
on the behavioural and neuronal responses to repeated 
nociceptive stimulation [31]. These data are not sur-
prising considering the distribution of sex hormones 
and their receptors in areas of the peripheral and cen-
tral nervous systems associated with nociceptive trans-
mission [32, 33]. Furthermore, sex hormones appear 
to modulate cortical processing of pain-related stimuli 
[34-36]. A regional increase in baseline μ-opioid recep-
tor availability and greater activation of endogenous 
opioid neurotransmission during pain in women in the 
high-estrogen state was also reported. During the low 
estrogen condition, however, significant reductions in 
endogenous opioid tone were observed at the level of 
the thalamus, nucleus accumbens and amygdala, which 
were associated with hyperalgesic responses [37]. The 
important effect on gonadal hormones by pain killers 
should be underlined. Data are clear concerning the hy-
pogonadism induced by opioids and other commonly 
used analgesics [38]. Thus the endocrinopathies occur-
ring in these patients can strongly affect their quality 
of life and the possibility to completely recover from 


















the original pathology. These findings suggest that the 
interaction of the opioidergic system with gonadal hor-
mones plays a role in the observed sex-based differenc-
es in pain sensitivity. 
Several studies have indicated that genotype may 
contribute to sex differences in pain. Since the early 
experimental data of Liebeskind and collaborators on 
mice strain differences in swimming-induced analgesia, 
preclinical research has shown that genotype influences 
nociception, and these findings have been extended 
to humans in recent years [39]. For example, heredi-
tary sensory and autonomic neuropathies (HSANs) 
are monogenic pain disorders in which pain sensibility 
is substantially absent. Rare inherited disorders may 
provide models to explain genetic variability in more 
common pain states and these syndromes appear to 
be linked to genes encoding proteins of different func-
tional classes, e.g. ion channels, enzymes, transcription 
factors and trophic factors. From genetic association 
studies, a wide variety of genes have now been asso-
ciated with both experimental and clinical pain states, 
and success in this field will lead both to a better under-
standing of basic pain mechanisms and to the develop-
ment of new therapies.
Many studies have suggested that interactions be-
tween the immune system and the nervous system 
modulate nociception via the crucial role of microglia. 
Recently, Sorge and collaborators [40] explored wheth-
er nociception can be processed in female mice through 
a pathway that is independent of microglia. The authors 
induced mechanical allodynia in mice of both sexes 
and found that intrathecal injection of glial inhibitors 
reversed allodynia in males but not in females. The 
transient depletion of microglia blocked allodynia in 
the male mice but not in the females. Furthermore, al-
lodynia was reversed in male but not in female mice by 
blocking signalling mediators linked to microglia-neu-
ron nociception pathways such as P2X4 receptor, p38 
MAP kinase or brain-derived neurotrophic factor. From 
these data the authors suggested that microglia are es-
sential for mechanical nociception in male mice, where-
as other mechanisms are probably used in females. To 
test whether adaptive immune cells are involved, the 
authors studied allodynia in nude or recombination-
activating gene 1-knockout (Rag1−/−) mice, which lack 
T cells and B cells. The administration of glial inhibi-
tors reversed allodynia in both male and female nude 
or Rag1−/− mice. In contrast, in female Rag1−/− mice re-
ceiving an adoptive transfer of splenocytes, allodynia 
could not be blocked by glial inhibitors, suggesting that 
female mice process nociception via lymphocyte-de-
pendent mechanisms but can use microglia-dependent 
pathways when lymphocytes are absent. Sex hormones 
also regulate the expression of peroxisome proliferator-
activated receptors (PPARs), which in turn can modify 
the expression of cytokines associated with nociception. 
Examining the sexually dimorphic expression of PPARs, 
the authors found that a PPARα agonist reversed allo-
dynia in males, but not in females or castrated males, 
whereas a PPARγ agonist reversed allodynia in females 
but not in males or testosterone-treated females. These 
findings appear to be important for future research on 
pain since they indicate the need for sex-separated ex-
perimental studies and further suggest that different 
clinical strategies could be adopted to optimize pain 
management in men and women.
CONCLUSIONS
Differences between men and women in pain prev-
alence, the seeking of medical treatment of pain syn-
dromes, pain behaviour and responses to analgesic drugs 
have long been reported. The role of social, cultural and 
biological factors in the sex difference in pain percep-
tion has been discussed. During the last two decades, a 
large amount of data has been collected on differences 
between the sexes in responses to pain, including pain 
thresholds, tolerance and response to pain treatments. 
Sex differences in nociception have been well docu-
mented in the literature. It has been shown that women 
perceive more pain than men and this has been dem-
onstrated for clinical pain and for experimental pain in 
humans and animals. Sex differences in pain perception 
are frequently substantial, with moderate to large effect 
sizes. Multiple factors are considered responsible for sex 
differences in pain perception and for the great preva-
lence of chronic pain conditions in women. Biological 
factors such as sex hormones are thought to be one of 
the main mechanisms explaining sex differences in pain 
perception. Further research to elucidate the mecha-
nisms underlying sex differences in pain responses is 
needed to reduce these disparities in pain.
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